BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
5 Wellbeing Applications Assist You With remaining Fit - 2Sahel coups push Africa to top of global democratic declines, report finds
- 3New dinosaur tracks in Italy illustrate herds moving in unison
- 4Central African Republic's president sworn in for a third term after disputed election
- 5Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- Fundamental Monetary Guidance for Going into Business
- Fuel Price Spike Drives Surge in Used EV Sales in Europe
- Space debris: will it take a catastrophe for nations to take the issue seriously?
- Jillian Michaels put me at the center of a body positivity debate. She's not entirely wrong about obesity.
- Drones haven't won the fight in Ukraine. That matters as the West learns new ways of war.
- Thousands of Walgreens nasal spray bottles recalled. See which ones.
- Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- ‘Wu-Tang Forever: The Final Chamber’ tour — How to get tickets, presale times, concert dates and more
- Most loved Solace Food: What's Your Definitive Comfortable Dinner?
